The Wegovy Paradox: Cheaper, Yet Still Out of Reach for Many

The Cost of Cures: Unraveling the High Price Tag on Biologic Drugs and the Persistent Push for Affordability

The Great Pharmaceutical Gridlock: How Patents Keep Prices Sky-High and Biosimilars at Bay

A Grand Bargain for Health? The Looming Question of Obesity Drugs and Who Pays.

The GLP-1 Gambit: Pharma Giants, Trump, and the High Stakes of Drug Prices

The Great Negotiation: Big Pharma, Weight Loss, and the White House

The Ghost in the Machine: How Trump's Drug Price Transparency Memo Almost Changed Everything—But Didn't

The Astonishing Disparity: Why Miebo's Price Tag is a World Apart Across the Atlantic

The Quiet Revolution: How the FDA is Finally Taking Aim at Sky-High Drug Prices

Biotech's Pulse Check: AI Rises, a Cancer Test Stumbles, and a Rare Disease Shines

The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets

The Great Weight Shift: Biotech's Quest for What's Next in Obesity Care

The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet

Trump Unleashes Trade Weapon Against Global Partners Over 'Unfair' Drug Prices

Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation

AstraZeneca's Landmark Deal: Lowering Drug Prices for Medicaid Under Trump Administration Agreement

Revolutionizing Healthcare: Trump's Bold Stance on Lowering Prescription Drug Costs

President Trump's Landmark Initiative to Tackle Skyrocketing Prescription Drug Costs

Rethinking Drug Costs: Trump's Bold Bid to Reshape Pharmaceutical Pricing

White House Shelves Generic Drug Tariffs, Paving the Way for Indian Pharma's Continued Success

Trump Extends Conditional Olive Branch to Democrats on Healthcare Amidst Shutdown Tensions

Trump's Pharma Tariffs: A Risky Gamble on American Innovation and Health

The Perilous Bargain: Are We Trading Future Cures for Today's Drug Savings?

Crucial Medicare Drug Price Loophole Fix Stalled: A Setback for Patient Savings

The Enduring Battle: Trump, Pfizer, and the Shifting Tides of Prescription Drug Pricing

TrumpRx Unveils Groundbreaking Platform to Dramatically Cut Prescription Drug Costs

Game Changer: Pfizer Secures Tariff Reprieve, Vows Lower Drug Prices for Millions of Americans

Trump Hails Landmark Pfizer Deal: $70 Million US Investment and Drug Price Cuts Announced

Trump Hails "Historic" Deal with Pfizer to Drastically Cut Drug Prices

Trump's Bold Move: White House Pressures Pharma Giants for Lower Drug Prices

Trump's Landmark Drug Price Promise: A Deadline Vanished, Unnoticed

Trump's Bold Pharmaceutical Tariff Plan: Unpacking the 'America First' Drug Strategy

Trump's Bold Pharmaceutical Tariff Plan: Unpacking the Potential Impacts on America's Drug Supply

Trump's Tariff Gamble: Experts Unpack the Real Cost of Pharma Duties

US Tariffs Threaten India's Generic Pharma Powerhouse: Himachal Manufacturers Sound Alarm

Trump's Tariff Vision: A Risky Prescription for Soaring Drug Costs and Shaken Supply Chains

Trump's Audacious Pharma Tariff Gamble: Will American Drug Prices Skyrocket?

Trump's Bold Pharmaceutical Tariff: A 100% Game Changer?

Trump's Tariff Tempest: Why a 100% Drug Tax Could Sink India's Pharma Giants and Ignite a US Healthcare Crisis